Rubicon Organics Future Growth
Future criteria checks 1/6
Rubicon Organics is forecast to grow earnings and revenue by 127.5% and 11.5% per annum respectively while EPS is expected to grow by 129.1% per annum.
Key information
127.5%
Earnings growth rate
129.1%
EPS growth rate
Pharmaceuticals earnings growth | 19.4% |
Revenue growth rate | 11.5% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 16 Aug 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2025 | 49 | 0 | N/A | 6 | 1 |
12/31/2024 | 46 | -2 | N/A | 3 | 1 |
6/30/2024 | 41 | -3 | 0 | 3 | N/A |
3/31/2024 | 40 | -3 | 1 | 4 | N/A |
12/31/2023 | 40 | -2 | 2 | 5 | N/A |
9/30/2023 | 41 | -5 | 3 | 7 | N/A |
6/30/2023 | 42 | -2 | 3 | 7 | N/A |
3/31/2023 | 39 | -3 | 0 | 4 | N/A |
12/31/2022 | 36 | -4 | -2 | 2 | N/A |
9/30/2022 | 31 | -2 | -4 | 0 | N/A |
6/30/2022 | 28 | -8 | -7 | -3 | N/A |
3/31/2022 | 24 | -12 | -10 | -6 | N/A |
12/31/2021 | 23 | -15 | -16 | -10 | N/A |
9/30/2021 | 21 | -18 | -20 | -14 | N/A |
6/30/2021 | 17 | -18 | -22 | -17 | N/A |
3/31/2021 | 13 | -15 | -23 | -17 | N/A |
12/31/2020 | 9 | -14 | -20 | -14 | N/A |
9/30/2020 | 5 | -12 | -21 | -14 | N/A |
6/30/2020 | 1 | -11 | -22 | -13 | N/A |
3/31/2020 | 0 | -12 | -21 | -12 | N/A |
12/31/2019 | N/A | -11 | -18 | -10 | N/A |
9/30/2019 | -1 | -9 | -16 | -11 | N/A |
6/30/2019 | -1 | -10 | -19 | -11 | N/A |
3/31/2019 | 0 | -25 | -16 | -7 | N/A |
12/31/2018 | N/A | -25 | -18 | -9 | N/A |
9/30/2018 | 2 | -26 | -19 | -10 | N/A |
6/30/2018 | 1 | -23 | -11 | -5 | N/A |
3/31/2018 | 1 | -8 | N/A | -7 | N/A |
12/31/2017 | 1 | -6 | N/A | -4 | N/A |
12/31/2016 | 2 | 2 | N/A | 0 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: R07 is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: R07 is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: R07 is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: R07's revenue (11.5% per year) is forecast to grow faster than the German market (5.4% per year).
High Growth Revenue: R07's revenue (11.5% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if R07's Return on Equity is forecast to be high in 3 years time